No significant differences were observed for sirtuins, cytokines, lipid profile, glucose, and blood pressure.<h4>Conclusion</h4>Resveratrol increased serum Bcl-2 and cIAP2, and also reduced caspase 9 and circulating EPCs in postmenopausal women with chronic CHD, likely unrelated to circulating SIRT1 and SIRT3. Here, BCL2 is linked to coronary artery disorder.